The Pediatric VAD is a novel assist device for infants and very small children from 2 kg to 15 kg with congenital or acquired cardiac disease, allowing them to remain completely mobile while receiving the ventricular assistance they so desperately need. If successful, the device would be the first designed specifically to provide long-term cardiac support to these very special patients for whom no support technology currently exists.
“CFD analysis is playing a critical role in the design optimization of the PediaFlow,” comments LaunchPoint CFD expert, Dr. JingChun Wu. “In order to maximize hydrodynamic performance and to minimize induced blood damage, it is necessary for us to analyze the complex blood flow field and to optimize the flow path of the blood pump. By integrating ANSYS CFX with our internally developed design tools, geometric models, automatic mesh generators, and mathematical blood damage models, we are able to cost-effectively provide an optimized design for the complex pediatric ventricular assist device.”
The ANSYS CFX solution provides superior technology to deliver quick and accurate results, intuitive setup, wider applicability, and fewer required resources than other packages. Its superior performance is the result of proven, leading-edge technology in all elements of the software that provides its accuracy, reliability, speed and flexibility. ANSYS CFX delivers the ability to apply the most powerful and precise CFD analysis to virtually every fluid engineering problem, and is why LaunchPoint trusts the software for its Pediatric VAD, currently being developed.